Chronic hypertension in pregnancy

Minerva Ginecologica

Volumn 55, Issue 1, 2003, Pages 1-13

  Livingston, J C ^a   Maxwell, B D ^a   Sibai, B M ^a  

^a CARILION CLINIC   (United States)

Author keywords

Hypertension, adverse effects; Hypertension, diagnosis; Pregnancy

Indexed keywords

ACEBUTOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLOROTHIAZIDE; CHLORTALIDONE; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; ISRADIPINE; LABETALOL; LISINOPRIL; MAGNESIUM SULFATE; METHYLDOPA; METOPROLOL; NICARDIPINE; NIFEDIPINE; NITRENDIPINE; OXPRENOLOL; PINDOLOL; VERAPAMIL;

ANURIA; BIRTH DEFECT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CONGENITAL DISORDER; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DROWSINESS; FETUS DISEASE; FETUS DISTRESS; HEADACHE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPOSPADIAS; HYPOTENSION; INTRAUTERINE GROWTH RETARDATION; KIDNEY FAILURE; LIVER DISEASE; LOW BIRTH WEIGHT; LUNG HYPOPLASIA; MATERNAL MORBIDITY; MATERNAL MORTALITY; MULTIPLE ORGAN FAILURE; OLIGOHYDRAMNIOS; PATIENT COMPLIANCE; PERINATAL DEATH; PERINATAL MORBIDITY; PERINATAL MORTALITY; POLYDACTYLY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURITY; PRENATAL CARE; PUERPERIUM; REVIEW; RISK FACTOR; SOLUTIO PLACENTAE; SPINA BIFIDA; STROKE; TARGET ORGAN; THIRST; THROMBOCYTOPENIA; TREATMENT PLANNING; TREMOR; TUBULAR DYSFUNCTION;

ABRUPTIO PLACENTAE; ADULT; ANTIHYPERTENSIVE AGENTS; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PREVALENCE; PUERPERAL DISORDERS; RANDOMIZED CONTROLLED TRIALS; RISK;

EID: 0037322443     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (110)

1. National High Blood Pressure Education Program Working Group. National high blood pressure education program working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163:1691-712.
2. Samadi AR, Mayberry RM, Zaidi AA, Pleasant JC, McGhee N jr, Rice RJ. Maternal hypertension and associated pregnancy complications among African-American and other women in the United States. Obstet Gynecol 1996;87:557-63.
3. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;24:305-13.
4. Barton JR, Bergauer NK, Jacques DI, Coleman SK, Stanziano GJ, Sibai BM. Does advanced maternal age affect pregnancy outcome in women with mild hypertension remote from term? Am J Obstet Gynecol 1997;176:1236-49; discussion 1240-3.
5. Ventura SI, Martin JA, Taftel SM, Mathews TJ, Clarke SC. Advance report of final natality statistics, 1993. Mon Vital Stat Rep 1995;44(3 Suppl):1-88.
6. Sibai BM, Akl S, Fairlie F, Moretti M. A protocol for managing severe preeclampsia in the second trimester. Am J Obstet Gynecol 1990;163:733-8.
7. Benedetto C, Zonca M, Marozio L, Dolci C, Carandente F, Massobrio M. Blood pressure patterns in normal pregnancy and in pregnancy-induced hypertension, preeclampsia, and chronic hypertension. Obstet Gynecol 1996;88:503-10.
8. Sibai BM, Lindheimer M, Hauth J, Caritis S, VanDorsten P, Klebanoff M et al. Risk factors for preeclampsia, abruptio placenta, and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med 1998;339:667-71.
9. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
10. Sibai BM. Chronic hypertension in pregnancy. Clin Perinatol 1991;18:833-44.
11. American College of Obstetricians and Gynecologists. Chronic hypertension in pregnancy. In ACOG practice bulletin no. 29. Washington, DC.: American College of Obstetricians and Gynecologists, 2001.
12. Witlin AG, Sibai BM. Hypertensive diseases in pregnancy. In: Reece EA, Hobbins JC, editors. Medicine of the fetus and the mother. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1999.p.997-1020.
13. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002;100:369-77.
14. Sibai BM. Diagnosis and management of chronic hypertension in pregnancy. Obstet Gynecol 1991;78:451-61.
15. Sibai BM, Abdella TN, Anderson GD. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 1983;61:571-6.
16. Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 1990;162:960-6.
17. Sibai BM, Anderson GD. Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet Gynecol 1986;67:517-22.
18. Ferrer RL, Sibai BM, Murlow CD, Chiquette E, Stevens KR, Cornell J. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol 2000;96:849-60.
19. Arias F, Zamora J. Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension. Obstet Gynecol 1979;53:489-94.
20. Caritis S, Sibai B, Hauth J, Lindheimer M, VanDorsten P, Klebanoff M et al. Predictors of pre-eclampsia in women at high risk. Am J Obstet Gynecol 1998;179:946-51.
21. Chesley LC, Annito JE. Pregnancy in the patient with hypertensive disease. Am J Obstet Gynecol 1947;53:372-81.
22. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343:619-29.
23. Landesman R, Holz W, Scherr L. Fetal mortality in essential hypertension. Obstet Gynecol 1955;6:354-65.
24. Mabie WC, Pernoll ML, Biswas MK. Chronic hypertension in pregnancy. Obstet Gynecol 1986;67:197-205.
25. McCowan LM, Buist RG, North RA, Gamble G. Perinatal morbidity in chronic hypertension. Br J Obstet Gynecol 1996;103:123-9.
26. Redman CWG, Beilin LJ, Bonnar J, Ounsted MK. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 1976;2:753-6.
27. Weitz C, Khouzami V, Maxwell K, Johnson JWC. Treatment of hypertension in pregnancy with methyldopa, randomized double-blind study. Int J Gynaecol Obstet 1987;25:35-40.
28. Mabie WC, Ratts TE, Ramanathan KB, Sibai BM. Circulatory congestion in obese hypertensive women: a subset of pulmonary edema in pregnancy. Obstet Gynecol 1988;72:553-8.
29. Sibai BM, Villar MA, Mabie BC. Acute renal failure in hy by-pertensive disorders of pregnancy: pregnancy outcome and remote prognosis in 31 consecutive cases. Am J Obstet Gynecol 1990;162:777-83.
30. Ananth CV, Savitz DA, Bowes WA jr. Hypertensive disorders of pregnancy and stillbirth in North Carolina, 1988 to 1991. Acta Obstet Gynecol Scand 1995;74:788-93.
31. Jain L. Effect of pregnancy-induced and chronic hypertension on pregnancy outcome. J Perinatal 1997;17:425-7.
32. Rey E, Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 1994;171:410-6.
33. Haelterman E, Breart G, Paris-Llado J, Dramaix M, Tchobroutsky C. Effect of uncomplicated chronic bypertension on the risk of small-for-gestational age birth. Am J Epidemiol 1997;145:689-95.
34. Meis PJ, Goldenberg RL, Mercer BM, Iams JD, Moawad AH, Miodovnik M et al. The preterm prediction study: risk factors for indicated preterm births. Am J Obstet Gynecol 1998;178:562-7.
35. Gruppo di Studio Ipertensione in Gravidanza. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Br J Obstet Gynaecol 1998;105:718-22.
36. Hirsch M, Bar J, Bott-Kanner G, Kaplan B, Fuchs J, Ovadia J. Effect of the β-adrenergic blocker pindolol on platelet function in chronic hypertensive pregnancy. Hypertens Pregnancy 1996;15:193-202.
37. Steyn DW, Odendaal HJ. Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. Lancet 1997;350:1267-71.
38. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ 1990;301:587-9.
39. Lip GYH, Beevers M, Churchill D, Shaffer LM, Beevers DG. Effect of atenolol on birth weight. Am J Cardiol 1997;79:1436-8.
40. Lydakis C, Lip GYH, Beevers M, Beevers G. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999;12:541-7.
41. Montan S, Ingemarsson I, Marsal K, Sjoberg NO. Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics. BMJ 1992;304:946-9.
42. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996;335:257-65.
43. Leather HM, Humphreys DM, Baker P, Chadd MA. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet 1968;2:488-90.
44. Plouin PF, Breart G, Maillard F, Papiernik E, Relier JP. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. Br J Obstet Gynaecol 1988;95:868-76.
45. Sibai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol 1984;150:831-5.
46. Welt SI, Dorminy JH IIIrd, Jelovsek FR, Crenshaw MC, Gall SA. The effects of prophylactic management and therapeutics on hypertensive disease in pregnancy: preliminary studies. Obstet Gynecol 1981;57:557-65.
47. Lawrence MR, Broughton Pipkin F. Some observations on the effects of a calcium channel blocker, nitrendipine, in early human pregnancy. Br J Clin Pharmacol 1987;23:683-92.
48. Montan S, Anandakumar C, Arulkumaran S, Ingemarsson I, Ratnam SS. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension. Am J Obstet Gynecol 1993;168:152-6.
49. Cockburn J, Moar VA, Ounsted M, Redman CW. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982;1:647-9.
50. Mutch LM, Moar VA, Ounsted MK, Redman CW. Hypertension during pregnancy, with-and-without specific hypotensive treatment. II. The growth and development of the infant in the first year of life. Early Hum Dev 1977;1:59-67.
51. Briggs GG, Freeman RK, Yaffee SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998.
52. Cruikshank DJ, Robertson AA, Campbell DM, MacGillivray I. Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomized controlled study. Eur J Obstet Gynecol Reprod Biol 1992;45:47-51.
53. Pickles CJ, Symonds EM, Pipkin FB. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol 1989;96:38-43.
54. Sibai BM, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of pre-eclampsia remote from term. Obstet Gynecol 1987;70(3 Pt 1):323-7.
55. Dubois D, Petitcolas J, Temperville B, Klepper A. Treatment of hypertension in pregnant women with β-blockers: 60 cases. Nouv Press Med 1980;9:2807-10.
56. Rubin PC, Butters L, Low RA, Clark DC. Atenolol in the management of hypertension during pregnancy. Drugs 1983;25Suppl 2:212-4.
57. Rubin PC, Butters L, Low RA, Reid JL. Atenolol in the treatment of essential hypertension during pregnancy. Br J Clin Pharmacol 1982;14:279-81.
58. Reynolds B, Butters L, Evans J, Adams T, Rubin PC. First year of life after the use of atenolol in pregnancy associated hypertension. Arch Dis Child 1984;59:1061.
59. Rubin PC, Butters L, Clark D, Sumner D, Belfield A, Pledger D et al. Obstetric aspects of the use in pregnancy-associated hypertension of the β-adrenoreceptor antagonist atenolol. Am J Obstet Gynecol 1984;150:389-92.
60. Rubin PC, Butters L, Clark DM, Reynolds B, Sumner DJ, Steedman D et al. Placebo-controlled trial of atenolol in treatment of pregnancy-hypertension. Lancet 1983;1:431-4.
61. Williams ER, Morrissey R. A comparison of acebutolol with methyldopa in hypertensive pregnancy. Pharmatherapeutica 1983;3:487-91.
62. Fidler J, Smith V, Fayers P, De Swiet M. Randomised controlled comparative study of methyldopa and oxprenolol in the treatment of hypertension in pregnancy. BMJ 1983;286:1927-30.
63. Gallery ED, Ross MR, Gyory AZ. Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. BMJ 1985;291:563-6.
64. Gallery ED, Saunders DM, Hunyor SN, Gyory AZ. Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. BMJ 1979;1:1591-4.
65. Goodnick PJ. Verapamil prophylaxis in pregnant women with bipolar disorder [letter]. Am J Psychiatry 1993;150:1560.
66. Lubbe WF. Use of diltiazem during pregnancy. N Z Med J 1987;100:121.
67. Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996;174:823-8.
68. Shen O, Entebi E, Yagel S. Congenital hypertrophic cardiomyopathy associated with in utero verapamil exposure [letter]. Prenat Diagn 1995;15:1088-9.
69. Sibai BM, Barton JR, Akl S, Sarinoglu C, Mercer BM. A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol 1992;167(4 Pt 1):879-84.
70. Jannet D, Carbonne B, Sebban E, Milliez J. Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial. Obstet Gynecol 1994;84:354-9.
71. Montan S, Anandakumnar C, Arulkumaran S, Ingemarsson I, Ratnam S. Randomised controlled trial of methyldopa and isradipine in pre-eclampsia. Effects on uteroplacental and fetal hemodynamics. J Perinat Med 1996;24:177-84.
72. Wide-Swensson DH, Ingermarsson I, Lunell NO, Forman A, Skajaa K, Lindberg B et al. Calcium channel blockade (isradipine) in the treatment of hypertension in pregnancy: a randomized placebo-controlled study. Am J Obstet Gynecol 1995;173(3 Pt 1):872-8.
73. Umans JG, Lindheimer MD. Antihypertensive treatment. In: Lindheimer MD, Roberts JM, Cunningham FG, editors. Chesley's hypertensive disorders in pregnancy. 2nd ed. Norwalk: Appleton and Lange; 1998.p.581-604.
74. Impey L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy-induced hypertension at 33 weeks. Br J Obstet Gynaecol 1993;100:959-61.
75. Livingston JC, Mabie B, Ramanathan J. Myocardial infarction and troponin levels at the time of Cesarean Section. Anesth Analg 2000;91:913-5.
76. Oei SG, Oei SK, Brolmann HA. Myocardial infarction during nifedipine therapy for preterm labor [letter]. N Engl J Med 1999;340:154.
77. Stoll C, Levy JM, Beshara D. Roberts' syndrome and clonidine. J Med Genet 1979;16:486-7.
78. Horvath JS, Phippard A, Korda A, Henderson-Smart DJ, Child A, Tiller DJ. Clonidine hydrochloride: a safe and effective antihypertensive agent in pregnancy. Obstet Gynecol 1985;66:634-8.
79. Phippard AF, Fischer WE, Horvath JS, Child AG, Korda AR, Henderson-Smart D et al. Early blood pressure control improves pregnancy outcome in primigravid women with mild hypertension. Med J Aust 1991;154:378-82.
80. August P, Lindheimer MD. Chronic hypertension and pregnancy. In: Lindheimer MD, Roberts JM, Cunningham FG, editors. Chesley's hypertensive disorders in pregnancy. 2nd ed. Norwalk: Appleton and Lange; 1998.p.605-33.
81. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton: Publishing Sciences Group; 1977.p.371-3.
82. Collins R, Yusuf S, Peto R. Overview of randomized trials of diuretics in pregnancy. Br Med J 1985;290:17-23.
83. Leikin SL. Thiazide and neonatal thrombocytopenia [letter]. N Engl J Med 1964;271:161.
84. Menzies DN. Controlled trial of chlorothiazide in treatment of early pre-eclampsia. BMJ 1964;1:739-42.
85. Prescott LF. Neonatal thrombocytopenia and thiazide drugs [letter]. BMJ 1964;1:1438.
86. Rodriguez SU, Leikin SL, Hiller MC. Neonatal thrombocytopenia associated with antepartum administration of thiazide drugs. N Engl J Med 1964;270:881-4.
87. Finnerty FA jr. Thiazide and neonatal thrombocytopenia [letter]. N Engl J Med 1964;271:1.
88. Jerkner K, Kutti J, Victorin L. Platelet counts in mothers and their newborn infants with respect to ante-partum administration of oral diuretics. Acta Med Scand 1973;194:473-5.
89. Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991;78:128-35.
90. Cunniff C, Jones KL, Phillipson J, Benirschke K, Short S, Wujek J. Oligohydramnios sequence and renal tubular malformation associated with maternal enalapril use. Am J Obstet Gynecol 1990;162:187-9.
91. Lavoratti G, Seracini D, Fiorini P, Cocchi C, Materassi M, Donzelli G et al. Neonatal anuria by ACE inhibitors during pregnancy [letter]. Nephron 1978;76:235-6.
92. Piper JM, Ray WA, Rosa FW. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstet Gynecol 1992;80(3 Pt 1):429-32.
93. Thorpe-Beeston JG, Armar NA, Dancy M, Cochrane GW, Ryan G, Rodeck CH. Pregnancy and ACE inhibitors. Br J Obstet Gynaecol 1993;100:692-3.
94. Buttar HS. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 1997;176:61-71.
95. Pryde PG, Sedman AB, Nugent CE, Barr M jr. Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 1993;3:1575-82.
96. Anonymous. From the Centers of Disease Control and Prevention. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995. JAMA 1997;277:1193-4.
97. Anonymous. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995. MMWR 1997;46:240-2.
98. Bar J, Hod M, Merlob P. Angiotensin-converting enzyme inhibitors use in the first trimester of pregnancy. Int J Risk Saf Med 1997;10:23-6.
99. Hogstedt S, Lindeberg S, Axelsson O, Lindmark G, Rane A, Sandstrom B et al. A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy. Acta Obstet Gynecol Scand 1985;64:505-10.
100. Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1985;1:840-2.
101. Viinikka L, Hartikainen-Sorri AL, Lumme R, Hiilesmaa V, Ylikorkala O. Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. Br J Obstet Gynaecol 1993;100:809-15.
102. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E et al. Low-dose aspirin to prevent pre-eclampsia in women at high risk. N Engl J Med 1998;338:701-5.
103. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ et al. Effect of antioxidants on the occurrence of pre-eclampsia in patients at increased risk: a randomized trial. Lancet 1999;354:810-6.
104. Mabie WC, Gonzalez AR, Sibai BM, Amon E. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 1987;70:328-33.
105. Pfeffer MA, Braunwald E, Moyé LA, for the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trials. N Engl J Med 1992;327:669-77.
106. Yusuf S, Peto R, Lewis J, Collins R, Sleigh P. β-blockade during and after myocardia infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
107. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group. The effect of angiotension converting inhibition on diabetic nephropathy. N Engl J Med 1993;329:145-62.
108. White WB. Management of hypertension during lactation. Hypertension 1984;6:297-300.
109. Atkinson H, Begg EJ. Concentrations of β-blocking drugs in human milk. J Pediatr 1990;116:156.
110. Ehrenkranz RA, Ackerman BA, Hulse JD. Nifedipine transfer into human milk. J Pediatr 1989;114:478-80.